With employees located across the globe, we maintain a collaborative, flexible culture that encourages discovery, professional development, and continual improvement. Our growing team includes people with various backgrounds who share a love for science and the goal of empowering scientists by providing the best next generation sequencing technology to accelerate their research.
Building on core strengths of molecular reagent design and workflow engineering, seqWell’s product portfolio allows improvements in the scale and quality of DNA sequencing results. Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell™ has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.
It’s a mission that our diverse team is committed to accomplishing. seqWell was built around the simple idea that innovative reagent-based solutions can eliminate many time- and cost-consuming elements of library prep. seqWell’s technologies will enable more research, optimize lab efficiency and maximize NGS technology. New products, technologies and challenges are on the horizon and we need your help to meet these challenges with creativity and fervor.
Interested in joining our team? Feel free to email us at [email protected]
This award recognizes companies that provide opportunities for personal and professional development. seqWell has supported their employees during this difficult year and has ensured a great work environment for all.
Frank A. Middleton, Ph.D.
Professor Director, SUNY Molecular Analysis CoreState University of New York (SUNY) Upstate Medical University
Joseph C. Mellor, Ph.D.
Co-founder and Chief Scientific Officer of seqWell Inc.